M. Sinan Beksaç, Diclehan Orhan, Beril Talim, Şule Yiğit, Murat Yurdakök, Zuhal Akçören, Gökçen Örgül, Gülen Eda Utine, Osman Koray Boduroğlu, Şafak Güçer, Gözdem Kaykı

Non-immune hydrops fetalis: A retrospective analysis of 151 autopsies performed at a single center

We retrospectively evaluated autopsies performed on 151 non-immune hydropsfetalis (NIHF) cases to determine the etiology and pathological findings.Further, cases identified between 1980 and 2004 were compared with thoseidentified between 2005 and 2015 to investigate the improvement of diagnosticperformance of our institution. The mean gestational age during the fetalautopsy was 25 weeks. There were 30 live-born infants in the study group.The etiology of NIHF could be determined in 91 cases (60.3%), while itremained undefined in remaining 60 cases. The most commonly associatedpathological conditions were cardiovascular malformations (11.3%), followedby chromosomal abnormalities (9.3%). Prior to 20th gestation week, geneticanomalies and cystic hygromas were the most common etiological factors,and after 30 weeks of gestation, cardiac abnormalities were found to bethe most common causes. With time, the rate of undefined cases decreasedfrom 48.4% to 33.75%. NIHF is a complex medical condition necessitating amultidisciplinary management approach. Progress in molecular genetics andimaging techniques is expected to improve diagnostic performance for rapidand better identification.

PDF

___

1. Norton ME, Chauhan SP, Dashe JS; Society for MaternalFetal Medicine (SMFM). Society for maternal-fetal medicine (SMFM) clinical guideline# 7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015; 212: 127- 139.
2. Bellini C, Hennekam RC, Fulcheri E, et al. Etiology of nonimmune hydrops fetalis: A systematic review. Am J Med Genet A 2009; 149A: 844-851.
3. Ismail K, Martin W, Ghosh S, Whittle MJ, Kilby MD. Etiology and outcome of hydrops fetalis. J Matern Fetal Neonatal Med 2001; 10: 175-181.
4. Ota S, Sahara J, Mabuchi A, Yamamoto R, Ishii K, Mitsuda N. Perinatal and one‐year outcomes of non‐immune hydrops fetalis by etiology and age at diagnosis. J Obstet Gynaecol Res 2016; 42: 385-391.
5. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand 2001; 80: 726-730.
6. Anandakumar C, Biswas A, Wong YC, et al. Management of non‐immune hydrops: 8 years' experience. Ultrasound Obstet Gynecol 1996; 8: 196-200.
7. Carlson DE, Platt LD, Medearis AL, Horenstein J. Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol 1990; 163(6 Pt 1): 1785-1787.
8. Rodríguez MM, Chaves F, Romaguera RL, Ferrer PL, De la Guardia C, Bruce JH. Value of autopsy in nonimmune hydrops fetalis: Series of 51 stillborn fetuses. Pediatr Dev Pathol 2002; 5: 365-374.
9. Santolaya J, Alley D, Jaffe R, Warsof SL. Antenatal classification of hydrops fetalis. Obstet Gynecol 1992; 79: 256-259.
10. Beksac MS, Saygan-Karamürsel B, Ustacelebi Ş, et al. Prenatal diagnosis of intrauterine cytomegalovirus infection in a fetus with non-immune hydrops fetalis. Acta Obstet Gynecol Scand 2001; 80: 762-765.
11. van Kamp IL, Klumper FJ, Bakkum RS, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001; 185: 668-673.
12. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: A role for direct fetal intramuscular therapy. Am J Perinatol 1996; 13: 483-486.
13. Turgal M, Ozyuncu O, Boyraz G, Yazicioglu A, Beksac MS. Non-immune hydrops fetalis as a diagnostic and survival problems: What do we tell the parents? J Perinat Med 2015; 43: 353-358.
14. Bellini C, Hennekam RC. Non‐immune hydrops fetalis: A short review of etiology and pathophysiology. Am J Med Genet A 2012; 158A: 597-605.
15. Liao C, Wei J, Li Q, Li J, Li L, Li D. Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China. Fetal Diagn Ther 2007; 22: 302-305.
16. Désilets V, Audibert F; Society of Obstetrician and Gynaecologists of Canada. Investigation and management of non-immune fetal hydrops. J Obstet Gynaecol Can 2013; 35: 923-938.
17. Beksac MS, Ozlu T, Dikensoy E, Cebesoy B. Management of severe non immune hydrops fetalis cases: The role of diagnostic and/or therapeutic interventions. Gynecol Obstet Reprod Med 2009; 15: 85-88.
18. Bellini C, Donarini G, Paladini D, et al. Etiology of non‐immune hydrops fetalis: An update. Am J Med Genet A 2015; 167A: 1082-1088.
19. Takci S, Gharibzadeh M, Yurdakok M, et al. Etiology and outcome of hydrops fetalis: Report of 62 cases. Pediatr Neonatol 2014; 55: 108-113.
20. Parks WT. A pathologist’s approach to nonimmune hydrops. J Fetal Med 2015; 2: 143-149.
21. Fukushima K, Morokuma S, Fujita Y, et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev 2011; 87: 571-575.
22. Heinonen S, Ryynänen M, Kirkinen P. Etiology and outcome of second trimester non‐immunologic fetal hydrops. Acta Obstet Gynecol Scand 2000; 79: 15-18.